NEW YORK, Nov 23 (Reuters) - A federal judge has dismissed a lawsuit alleging that Merck & Co's osteoporosis drug Fosamax causes jaw damage, more than two months after a jury deadlocked in a case involving a similar claim. U.S. District Judge John Keenan on Monday found that Bessie Flemings, 74, a Mississippi resident, failed to present enough evidence to show that her use of Fosamax caused ...

[News Source]